Phase 1 Trigeminal Neuralgia Clinical Trials
3 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
RP-008 in Combination With Daily Oral Varenicline for the Treatment of Trigeminal Neuralgia
Trigeminal Neuralgia
Kriya Therapeutics, Inc.24 enrolled1 locationNCT07596485
Recruiting
Phase 1
Safety of Cultured Allogeneic Adult Umbilical Cord Stem Cells Exosomes for Trigeminal Neuralgia
Peripheral NeuropathyTrigeminal Neuralgia
The Foundation for Orthopaedics and Regenerative Medicine20 enrolled1 locationNCT05152368
Recruiting
Phase 1
Deep Brain Stimulation for Refractory Trigeminal Neuralgia with a Pontine Lesion
Trigeminal Neuralgia
Université de Sherbrooke6 enrolled1 locationNCT05451251